Coya Therapeutics annual operating expenses
2021
2022
2023
2024
2025
Coya Therapeutics Operating Expenses Growth & History (COYA)
Coya Therapeutics's operating expenses was $30.5M for fiscal 2025.
View full Coya Therapeutics company overviewCoya Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $30.5M | $9.7M | +46.61% |
| 2024 | 2024-12-31 | $20.8M | $6.9M | +49.61% |
| 2023 | 2023-12-31 | $13.9M | $4.1M | +41.72% |
| 2022 | 2022-12-31 | $9.8M | $4.9M | +101.46% |
| 2021 | 2021-12-31 | $4.9M | — | — |
Coya Therapeutics quarterly operating expenses
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7.3M | $712,599 | +10.83% |
| Q1 2026 | 2026-03-31 | $7.9M | −$43,442 | −0.55% |
| Q4 2025 | 2025-12-31 | $10.0M | $5.9M | +144.74% |
| Q3 2025 | 2025-09-30 | $6.0M | $1.5M | +34.76% |
| Q2 2025 | 2025-06-30 | $6.6M | −$83,262 | −1.25% |
| Q1 2025 | 2025-03-31 | $7.9M | $2.3M | +41.44% |
| Q4 2024 | 2024-12-31 | $4.1M | −$104,804 | −2.50% |
| Q3 2024 | 2024-09-30 | $4.5M | $886,226 | +24.87% |
| Q2 2024 | 2024-06-30 | $6.7M | $3.4M | +104.69% |
| Q1 2024 | 2024-03-31 | $5.6M | $2.7M | +93.44% |
| Q4 2023 | 2023-12-31 | $4.2M | $2.2M | +108.98% |
| Q3 2023 | 2023-09-30 | $3.6M | $902,192 | +33.89% |
| Q2 2023 | 2023-06-30 | $3.3M | −$191,844 | −5.57% |
| Q1 2023 | 2023-03-31 | $2.9M | $1.2M | +70.56% |
| Q4 2022 | 2022-12-31 | $2.0M | — | — |
| Q3 2022 | 2022-09-30 | $2.7M | — | — |
| Q2 2022 | 2022-06-30 | $3.4M | — | — |
| Q1 2022 | 2022-03-31 | $1.7M | — | — |
Coya Therapeutics operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, Coya Therapeutics's operating expenses increased from $4.9M to $30.5M, a change of $25.6M. The latest reported quarter, Q2 2026, shows $7.3M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Coya Therapeutics source filings ↗